Ocular Therapeutix (OCUL) Change in Account Payables (2013 - 2026)

Ocular Therapeutix's Change in Account Payables history runs 14 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 53028.57% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $2.8 million (up 240.97% YoY), while the FY2025 annual figure was -$887000.0, down 178.93% from the prior year.
• Change in Account Payables was $3.7 million for Q1 2026 at Ocular Therapeutix, up from -$1.4 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.7 million in Q1 2026 to a low of -$2.4 million in Q2 2024.
• Historically, Change in Account Payables has averaged $145647.1 across 5 years, with a median of $247000.0 in 2023.
• The sharpest annual moves came in 2025 and 2026: Change in Account Payables tumbled 1308.04% in 2025, then jumped 53028.57% in 2026.
• A 5-year view of Change in Account Payables shows it stood at -$1.1 million in 2022, then surged by 158.47% to $656000.0 in 2023, then sank by 82.93% to $112000.0 in 2024, then sank by 1308.04% to -$1.4 million in 2025, then soared by 374.87% to $3.7 million in 2026.
• The last three Change in Account Payables figures came in at $3.7 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.